References
- Winter AK, Moss WJ. Rubella. Lancet. 2022;399(10332):1336–1346. doi:10.1016/S0140-6736(21)02691-X.
- Cooper LZ. The history and medical consequences of rubella. Rev Infect Dis. 1985;7(Suppl 1(April)):S2–S10. doi:10.1093/clinids/7.supplement_1.s2.
- Kiziltoprak H, Yetkin E, Tekin K, Koc M, Akalin İ, Teke MY. Intravitreal aflibercept for the treatment of choroidal neovascularization associated with rubella retinopathy. Int Ophthalmol. 2019;39(2):477–484. doi:10.1007/s10792-018-0830-5.
- Dewan L, Hasan N, Aron N, Chawla R, Sundar D. Rubella retinopathy with choroidal neovascular membrane in a 7-year-old. Indian J Ophthalmol. 2020;68(6):1176–1177. doi:10.4103/ijo.IJO_1469_19.
- Wang LK, Kansal S, Pulido JS. Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy. Am J Ophthalmol. 2002;134(5):790–792. doi:10.1016/s0002-9394(02)01647-1.
- Veloso CE, Costa RA, Oréfice JL, Oréfice F. Spontaneous involution of choroidal neovascularization secondary to rubella retinopathy. Eye (Lond). 2007;21(11):1429–1430. doi:10.1038/sj.eye.6702940.
- Hirano K, Tanikawa A, Miyake Y. Neovascular maculopathy associated with rubella retinopathy. Jpn J Ophthalmol. 2000;44(6):697. doi:10.1016/s0021-5155(00)00266-5.
- Slusher MM, Tyler ME. Rubella retinopathy and subretinal neovascularization. Ann Ophthalmol. 1982;14(3):292–294. http://www.ncbi.nlm.nih.gov/pubmed/6178346
- Frank KE, Purnell EW. Subretinal neovascularization following rubella retinopathy. Am J Ophthalmol. 1978;86(4):462–466. doi:10.1016/0002-9394(78)90290-8.
- Orth DH, Fishman GA, Segall M, Bhatt A, Yassur Y. Rubella maculopathy. Br J Ophthalmol. 1980;64(3):201–205. doi:10.1136/bjo.64.3.201.